These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
495 related items for PubMed ID: 16546900
1. Effects of boron neutron capture therapy on human oral squamous cell carcinoma in a nude mouse model. Kamida A, Obayashi S, Kato I, Ono K, Suzuki M, Nagata K, Sakurai Y, Yura Y. Int J Radiat Biol; 2006 Jan; 82(1):21-9. PubMed ID: 16546900 [Abstract] [Full Text] [Related]
2. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy. Obayashi S, Kato I, Ono K, Masunaga S, Suzuki M, Nagata K, Sakurai Y, Yura Y. Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618 [Abstract] [Full Text] [Related]
3. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy. Masunaga S, Sakurai Y, Suzuki M, Nagata K, Maruhashi A, Kinash Y, Ono K. Int J Radiat Oncol Biol Phys; 2004 Nov 01; 60(3):920-7. PubMed ID: 15465210 [Abstract] [Full Text] [Related]
4. Insight into the mechanisms underlying tumor response to boron neutron capture therapy in the hamster cheek pouch oral cancer model. Aromando RF, Heber EM, Trivillin VA, Nigg DW, Schwint AE, Itoiz ME. J Oral Pathol Med; 2009 May 01; 38(5):448-54. PubMed ID: 19141057 [Abstract] [Full Text] [Related]
5. Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer. Dagrosa MA, Thomasz L, Longhino J, Perona M, Calzetta O, Blaumann H, Rebagliati RJ, Cabrini R, Kahl S, Juvenal GJ, Pisarev MA. Int J Radiat Oncol Biol Phys; 2007 Nov 15; 69(4):1059-66. PubMed ID: 17967301 [Abstract] [Full Text] [Related]
6. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy. Masunaga S, Nagasawa H, Hiraoka M, Sakurai Y, Uto Y, Hori H, Nagata K, Suzuki M, Maruhashi A, Kinashi Y, Ono K. Anticancer Res; 2004 Nov 15; 24(5A):2975-83. PubMed ID: 15517904 [Abstract] [Full Text] [Related]
10. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA. Chou FI, Chung HP, Liu HM, Chi CW, Lui WY. Appl Radiat Isot; 2009 Jul 15; 67(7-8 Suppl):S105-8. PubMed ID: 19375330 [Abstract] [Full Text] [Related]
11. The hamster cheek pouch as a model of oral cancer for boron neutron capture therapy studies: selective delivery of boron by boronophenylalanine. Kreimann EL, Itoiz ME, Dagrosa A, Garavaglia R, Farías S, Batistoni D, Schwint AE. Cancer Res; 2001 Dec 15; 61(24):8775-81. PubMed ID: 11751398 [Abstract] [Full Text] [Related]
12. Effect of Boron Neutron Capture Therapy (BNCT) on normal liver regeneration: towards a novel therapy for liver metastases. Cardoso JE, Trivillin VA, Heber EM, Nigg DW, Calzetta O, Blaumann H, Longhino J, Itoiz ME, Bumaschny E, Pozzi E, Schwint AE. Int J Radiat Biol; 2007 Oct 15; 83(10):699-706. PubMed ID: 17729164 [Abstract] [Full Text] [Related]
13. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy. Smith DR, Chandra S, Barth RF, Yang W, Joel DD, Coderre JA. Cancer Res; 2001 Nov 15; 61(22):8179-87. PubMed ID: 11719448 [Abstract] [Full Text] [Related]
15. Boron neutron capture therapy for undifferentiated thyroid carcinoma: preliminary results with the combined use of BPA and BOPP. Viaggi M, Dagrosa MA, Longhino J, Blaumann H, Calzetta O, Kahl SB, Juvenal GJ, Pisarev MA. Appl Radiat Isot; 2004 Nov 15; 61(5):905-9. PubMed ID: 15308166 [Abstract] [Full Text] [Related]
16. Boron neutron capture therapy (BNCT) inhibits tumor development from precancerous tissue: an experimental study that supports a potential new application of BNCT. Monti Hughes A, Heber EM, Pozzi E, Nigg DW, Calzetta O, Blaumann H, Longhino J, Nievas SI, Aromando RF, Itoiz ME, Trivillin VA, Schwint AE. Appl Radiat Isot; 2009 Jul 15; 67(7-8 Suppl):S313-7. PubMed ID: 19376711 [Abstract] [Full Text] [Related]
17. Therapeutic success of boron neutron capture therapy (BNCT) mediated by a chemically non-selective boron agent in an experimental model of oral cancer: a new paradigm in BNCT radiobiology. Trivillin VA, Heber EM, Nigg DW, Itoiz ME, Calzetta O, Blaumann H, Longhino J, Schwint AE. Radiat Res; 2006 Aug 15; 166(2):387-96. PubMed ID: 16881740 [Abstract] [Full Text] [Related]
18. Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy. Dagrosa MA, Viaggi M, Rebagliati RJ, Batistoni D, Kahl SB, Juvenal GJ, Pisarev MA. Mol Pharm; 2005 Aug 15; 2(2):151-6. PubMed ID: 15804189 [Abstract] [Full Text] [Related]
19. The effect of dexamethasone on the uptake of p-boronophenylalanine in the rat brain and intracranial 9L gliosarcoma. Morris GM, Micca PL, Coderre JA. Appl Radiat Isot; 2004 Nov 15; 61(5):917-21. PubMed ID: 15308168 [Abstract] [Full Text] [Related]
20. Early effect of boron neutron capture therapy mediated by boronophenylalanine (BPA-BNCT) on mast cells in premalignant tissue and tumors of the hamster cheek pouch. Aromando RF, Trivillin VA, Heber EM, Pozzi E, Schwint AE, Itoiz ME. Oral Oncol; 2010 May 15; 46(5):355-9. PubMed ID: 20308008 [Abstract] [Full Text] [Related] Page: [Next] [New Search]